A Randomized Controlled Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations STEP
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Exemestane (Primary) ; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms STEP
- 28 Feb 2018 Phas has been changede IV to III.
- 19 Jun 2017 Status changed from not yet recruiting to recruiting.
- 05 May 2017 New trial record